1. Home
  2. RCKT vs IGIC Comparison

RCKT vs IGIC Comparison

Compare RCKT & IGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • IGIC
  • Stock Information
  • Founded
  • RCKT 1999
  • IGIC 2001
  • Country
  • RCKT United States
  • IGIC Jordan
  • Employees
  • RCKT N/A
  • IGIC N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • IGIC Property-Casualty Insurers
  • Sector
  • RCKT Health Care
  • IGIC Finance
  • Exchange
  • RCKT Nasdaq
  • IGIC Nasdaq
  • Market Cap
  • RCKT 1.3B
  • IGIC 1.0B
  • IPO Year
  • RCKT N/A
  • IGIC N/A
  • Fundamental
  • Price
  • RCKT $10.31
  • IGIC $23.98
  • Analyst Decision
  • RCKT Strong Buy
  • IGIC Buy
  • Analyst Count
  • RCKT 11
  • IGIC 3
  • Target Price
  • RCKT $50.27
  • IGIC $23.67
  • AVG Volume (30 Days)
  • RCKT 1.8M
  • IGIC 93.2K
  • Earning Date
  • RCKT 02-24-2025
  • IGIC 03-11-2025
  • Dividend Yield
  • RCKT N/A
  • IGIC 2.40%
  • EPS Growth
  • RCKT N/A
  • IGIC 32.83
  • EPS
  • RCKT N/A
  • IGIC 3.04
  • Revenue
  • RCKT N/A
  • IGIC $506,160,000.00
  • Revenue This Year
  • RCKT N/A
  • IGIC N/A
  • Revenue Next Year
  • RCKT $240,645.72
  • IGIC $6.64
  • P/E Ratio
  • RCKT N/A
  • IGIC $7.88
  • Revenue Growth
  • RCKT N/A
  • IGIC 10.67
  • 52 Week Low
  • RCKT $10.12
  • IGIC $11.51
  • 52 Week High
  • RCKT $31.47
  • IGIC $27.00
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 32.27
  • IGIC 48.91
  • Support Level
  • RCKT $10.12
  • IGIC $22.97
  • Resistance Level
  • RCKT $11.24
  • IGIC $24.83
  • Average True Range (ATR)
  • RCKT 0.71
  • IGIC 0.69
  • MACD
  • RCKT -0.09
  • IGIC 0.04
  • Stochastic Oscillator
  • RCKT 5.88
  • IGIC 54.30

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

Share on Social Networks: